This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhoufan Xie: Innovator in Pharmaceutical Compounds
Introduction
Zhoufan Xie is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications. His work is characterized by a focus on innovative chemical structures that can inhibit specific biological pathways.
Latest Patents
Zhoufan Xie holds 1 patent for his invention of 6,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RET. This patent discloses a class of compounds represented by formula (II), along with their isomers or pharmaceutically acceptable salts. The implications of this invention could be substantial in the treatment of diseases related to RET signaling.
Career Highlights
Zhoufan Xie is affiliated with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., specifically working at the Baiyunshan Pharmaceutical General Factory. His role in this esteemed organization allows him to contribute to the advancement of pharmaceutical research and development.
Collaborations
Zhoufan has collaborated with notable colleagues such as Rongxin Huang and Shuhui Chen. These partnerships enhance the innovative capacity of their projects and contribute to the overall success of their research endeavors.
Conclusion
Zhoufan Xie's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile